110 related articles for article (PubMed ID: 9106246)
1. Mutagenic activity of ambient oxygen and mitomycin C in Fanconi's anaemia cells.
Liebetrau W; Rünger TM; Mehling BE; Poot M; Hoehn H
Mutagenesis; 1997 Mar; 12(2):69-77. PubMed ID: 9106246
[TBL] [Abstract][Full Text] [Related]
2. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking.
Clarke AA; Philpott NJ; Gordon-Smith EC; Rutherford TR
Br J Haematol; 1997 Feb; 96(2):240-7. PubMed ID: 9029006
[TBL] [Abstract][Full Text] [Related]
3. Mutations induced in a shuttle vector plasmid exposed to monofunctionally activated mitomycin C.
Maccubbin AE; Mudipalli A; Nadadur SS; Ersing N; Gurtoo HL
Environ Mol Mutagen; 1997; 29(2):143-51. PubMed ID: 9118966
[TBL] [Abstract][Full Text] [Related]
4. Mutational response of Fanconi anaemia cells to shuttle vector site-specific psoralen cross-links.
Bredberg A; Sandor Z; Brant M
Carcinogenesis; 1995 Mar; 16(3):555-61. PubMed ID: 7697813
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment.
Kaiser TN; Lojewski A; Dougherty C; Juergens L; Sahar E; Latt SA
Cytometry; 1982 Mar; 2(5):291-7. PubMed ID: 6804195
[TBL] [Abstract][Full Text] [Related]
6. Kinds and spectrum of mutations induced by 1-nitrosopyrene adducts during plasmid replication in human cells.
Yang JL; Maher VM; McCormick JJ
Mol Cell Biol; 1988 Aug; 8(8):3364-72. PubMed ID: 3062380
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity and mutagenicity of the alpha, beta-unsaturated carbonyl compound crotonaldehyde (butenal) on a plasmid shuttle vector.
Czerny C; Eder E; Rünger TM
Mutat Res; 1998 Mar; 407(2):125-34. PubMed ID: 9637241
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanism underlying formation of deletions in Fanconi anemia cells may involve a site-specific recombination.
Laquerbe A; Moustacchi E; Fuscoe JC; Papadopoulo D
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):831-5. PubMed ID: 7846061
[TBL] [Abstract][Full Text] [Related]
10. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function.
Heinrich MC; Hoatlin ME; Zigler AJ; Silvey KV; Bakke AC; Keeble WW; Zhi Y; Reifsteck CA; Grompe M; Brown MG; Magenis RE; Olson SB; Bagby GC
Blood; 1998 Jan; 91(1):275-87. PubMed ID: 9414295
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase.
Kruyt FA; Dijkmans LM; Arwert F; Joenje H
Cancer Res; 1997 Jun; 57(11):2244-51. PubMed ID: 9187128
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells.
Saito H; Hammond AT; Moses RE
Mutat Res; 1993 Oct; 294(3):255-62. PubMed ID: 7692265
[TBL] [Abstract][Full Text] [Related]
13. Fanconi's anemia cell lines show distinct mechanisms of cell death in response to mitomycin C or agonistic anti-Fas antibodies.
Clarke AA; Gibson FM; Scott J; Myatt N; Rutherford TR
Haematologica; 2004 Jan; 89(1):11-20. PubMed ID: 14754601
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of spontaneously occurring mutations in the HPRT gene of the Chinese hamster V79 cell mutant V-H4, which is homologous to Fanconi anemia group A.
Telleman P; Overkamp WJ; Zdzienicka MZ
Mutagenesis; 1996 Mar; 11(2):155-9. PubMed ID: 8671732
[TBL] [Abstract][Full Text] [Related]
15. Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency.
Takeuchi T; Morimoto K
Carcinogenesis; 1993 Jun; 14(6):1115-20. PubMed ID: 8389671
[TBL] [Abstract][Full Text] [Related]
16. Fanconi anemia cells have a normal gene structure for topoisomerase I.
Saito H; Grompe M; Neeley TL; Jakobs PM; Moses RE
Hum Genet; 1994 May; 93(5):583-6. PubMed ID: 8168839
[TBL] [Abstract][Full Text] [Related]
17. In-vivo assessment of DNA ligation efficiency and fidelity in cells from patients with Fanconi's anemia and other cancer-prone hereditary disorders.
Rünger TM; Sobotta P; Dekant B; Möller K; Bauer C; Kraemer KH
Toxicol Lett; 1993 Apr; 67(1-3):309-24. PubMed ID: 8451768
[TBL] [Abstract][Full Text] [Related]
18. Mutations in a shuttle vector exposed to activated mitomycin C.
Srikanth NS; Mudipalli A; Maccubbin AE; Gurtoo HL
Mol Carcinog; 1994 May; 10(1):23-9. PubMed ID: 8185826
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi's anaemia phenotype.
Pagano G
Carcinogenesis; 2000 May; 21(5):1067-8. PubMed ID: 10783335
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea induces chromosomal damage in G2 and enhances the clastogenic effect of mitomycin C in Fanconi anemia cells.
Molina B; Marchetti F; Gómez L; Ramos S; Torres L; Ortiz R; Altamirano-Lozano M; Carnevale A; Frias S
Environ Mol Mutagen; 2015 Jun; 56(5):457-67. PubMed ID: 25663157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
